Table 2.
Association of CAR10 Expression with Clinicopathological Features of NSCLC
| Features | No. of Cases | CAR10 | p value† | |
|---|---|---|---|---|
| High | Low | |||
| Age (yrs) | 1.000 | |||
| ≤65 | 23 | 11 | 12 | |
| >65 | 27 | 14 | 13 | |
| Gender | 0.396 | |||
| Male | 24 | 14 | 10 | |
| Female | 26 | 11 | 15 | |
| Smoking history | 0.773 | |||
| Smokers | 30 | 14 | 16 | |
| Never smoker | 20 | 11 | 9 | |
| Histological subtype | 0.946 | |||
| AD | 18 | 8 | 10 | |
| SQC | 17 | 9 | 8 | |
| LCLC | 11 | 6 | 5 | |
| Carcinoid | 4 | 2 | 2 | |
| TNM stage | 0.019 | |||
| IA - IIB | 17 | 5 | 14 | |
| IIIA - IV | 33 | 20 | 11 | |
| Lymph node metastasis | 0.018 | |||
| Negative | 12 | 2 | 10 | |
| Positive | 38 | 23 | 15 | |
| Tumor size (cm) | 1.000 | |||
| ≤5 | 31 | 15 | 16 | |
| >5 | 19 | 10 | 9 | |
Note: †P-value obtained from Pearson Chi-Square test or Fisher’s exact test.
Abbreviations: AD, adenocarcinoma; SQC, squamous carcinoma; LCLC, large cell lung cancer.